Yinghai Xie Department of Hepatobiliary Surgery The First Affiliated Hospital of Anhui University of Science & Technology Biography Publications Institution JoVE Articles Yinghai Xie has not added a biography. If you are Yinghai Xie and would like to personalize this page please email our Author Liaison for assistance. Publications ASIC1α Up-regulates MMP-2/9 Expression to Enhance Mobility and Proliferation of Liver Cancer Cells Via the PI3K/AKT/mTOR Pathway BMC Cancer. Jul, 2022 | Pubmed ID: 35840921 ASIC1a Stimulates the Resistance of Human Hepatocellular Carcinoma by Promoting EMT Via the AKT/GSK3β/Snail Pathway Driven by TGFβ/Smad Signals Journal of Cellular and Molecular Medicine. May, 2022 | Pubmed ID: 35426224 Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway Nanoscale Research Letters. Dec, 2021 | Pubmed ID: 34914025 Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways Journal of Biomedical Nanotechnology. Nov, 2021 | Pubmed ID: 34906285 PKI-587 Enhances Radiosensitization of Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Pathways and DNA Damage Repair PloS One. 2021 | Pubmed ID: 34665844 BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy BioMed Research International. 2021 | Pubmed ID: 33987439 LY3214996 Relieves Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells International Journal of Medical Sciences. 2021 | Pubmed ID: 33628103 The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway Nanoscale Research Letters. Mar, 2020 | Pubmed ID: 32219609 BEZ235 Enhances Chemosensitivity of Paclitaxel in Hepatocellular Carcinoma Through Inhibiting the PI3K/Akt/mTOR Pathway American Journal of Translational Research. 2019 | Pubmed ID: 31934276 BEZ235 Increases Sorafenib Inhibition of Hepatocellular Carcinoma Cells by Suppressing the PI3K/AKT/mTOR Pathway American Journal of Translational Research. 2019 | Pubmed ID: 31632530 PKI-587 Enhances Chemosensitivity of Oxaliplatin in Hepatocellular Carcinoma Through Suppressing DNA Damage Repair Pathway (NHEJ and HR) and PI3K/AKT/mTOR Pathway American Journal of Translational Research. 2019 | Pubmed ID: 31497229 Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection Lei Xu*1,2, Manman Xu*3, Yinghai Xie4, Wei You2, Jianxin Wang2, Liwu Xu4, Qizhu Feng4, Jie Sun4, Jian Zhang4, Huaichen Yang4, Wang Qi4 1The First Affiliated Hospital of Anhui University of Science & Technology, 2Medical College of Anhui University of Science & Technology, 3Endocrinology Department, The First Affiliated Hospital of Anhui University of Science & Technology, 4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui University of Science & Technology JoVE 66780 Immunology and Infection
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection Lei Xu*1,2, Manman Xu*3, Yinghai Xie4, Wei You2, Jianxin Wang2, Liwu Xu4, Qizhu Feng4, Jie Sun4, Jian Zhang4, Huaichen Yang4, Wang Qi4 1The First Affiliated Hospital of Anhui University of Science & Technology, 2Medical College of Anhui University of Science & Technology, 3Endocrinology Department, The First Affiliated Hospital of Anhui University of Science & Technology, 4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui University of Science & Technology JoVE 66780 Immunology and Infection